MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features"

  • 2022 International Congress

    VALIDATING ACCELEROMETRY AS A MEASURE OF ENERGY EXPENDITURE AND PHYSICAL ACTIVITY IN ADULTS WITH HUNTINGTON’S DISEASE

    L. Simón, E. Cubo, J. Rivadeneyra, C. Collazo, M. Soto, J. Raya, D. Castillo, S. Calvo, A. Fernández (Burgos, Spain)

    Objective: to validate the use of accelerometers to quantify energy expenditure (EE) under controlled conditions for Huntington’s disease (HD) patients using Indirect Calorimetry (IC) as…
  • 2022 International Congress

    Very long time persistent hyperCKemia as the first manifestation of McLeod syndrome

    E. Muñoz, V. Torres, C. Painous, P. Santacruz, A. Sánchez, C. Sanz, JM. Grau-Junyent (Barcelona, Spain)

    Objective: To present a case of McLeod syndrome (MLS) with isolated muscle involvement for many years, which developed late-onset chorea leading to disease diagnosis. Background:…
  • 2022 International Congress

    Defining minimal clinically important differences in Huntington’s disease: An anchor-based approach

    J. Hamilton, J. Mills, G. Stebbins, J. Long, R. Fuller, S. Sathe, M. Roche, C. Sampaio (Princeton, USA)

    Objective: This study aims to estimate the longitudinal minimal clinically important difference (MCID) for HD-relevant, cognitive, motor, and functional outcome measures. We used the new…
  • 2022 International Congress

    All that emerge is not Lupus

    M. Spitz, S. de Souza, I. Sodré, B. Panichelli (Rio de Janeiro, Brazil)

    Objective: The aim of this article is to report a rare case of Huntington's disease (HD) in a patient with chorea and previous diagnosis of…
  • 2022 International Congress

    Reversible chorea due to bilateral basal ganglia lesion in diabetic uremic patient

    B. Tserensodnom (Ulaanbaatar, Mongolia)

    Objective: To report diabetic patient with chronic renal failure who developed sudden chorea movements associated with reversible bilateral basal ganglia lesion. Background: Acute movement disorder…
  • 2022 International Congress

    Juvenile Huntington’s Disease in Tunisia: Clinical Diversity and Literature review

    H. Nehdi, E. Chebbi, F. Nabli, Z. Saied, S. Ben Sassi, R. Amouri (Tunis, Tunisia)

    Objective: We conducted the first JHD clinical and molecular features in Tunisia and North Africa, contributing to better understanding the diverse manifestation of the disease…
  • 2022 International Congress

    Cognitive profiling in a cohort of Huntington’s disease (HD) patients

    M. Garon, F. Pistonesi, L. Weis, V. Cianci, T. Gandolfi, E. Fiorenzato, C. Tedesco, M. Campagnolo, M. Carecchio, A. Antonini, R. Biundo (Padua, Italy)

    Objective: To define neuropsychological profile of HD patients adopting Parkinson’s disease Level II criteria for cognitive diagnosis[1]. Background: HD is a rare autosomal dominant genetic…
  • 2022 International Congress

    Mimics or multiplicity: two patients with a PSP phenotype and underlying genetic neurodegenerative disorders.

    S. Lyons, R. Walsh, T. Lynch, S. O'Dowd (Dublin, Ireland)

    Objective: To describe a two cases of patients presenting with a PSP phenotype and genetic findings consisted with Huntington’s disease (HD) in one case and…
  • 2022 International Congress

    Nocturnal attacks of abnormal sleep behaviors and abnormal movements induced by insulin: A case report

    S. El-Jaafary (Cairo, Egypt)

    Objective: To report a case of abnormal sleep behavior associated with hypoglycemia induced by insulin. Background: Hypoglycemia is a serious condition that can be manifested…
  • 2022 International Congress

    Speech markers of Presymptomatic and Prodromal Huntington’s disease

    A. Vogel, C. Chan, G. Stuart, P. Maruff, Y. Lie, J. Stout (Melbourne, Australia)

    Objective: To investigate the sensitivity of digital speech measures for detecting subtle cognitive-linguistic and fine motor features in people carrying the expanded HD gene, with…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley